Pharmagreen Biotech (Pharmagreen Biotech) EV-to-EBITDA : -1.96 (As of May. 21, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Pharmagreen Biotech's enterprise value is $0.79 Mil. Pharmagreen Biotech's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.41 Mil. Therefore, Pharmagreen Biotech's EV-to-EBITDA for today is -1.96.

The historical rank and industry rank for Pharmagreen Biotech's EV-to-EBITDA or its related term are showing as below:

PHBI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -412.09 Med: 0 Max: 471
Current: -1.96

During the past 7 years, the highest EV-to-EBITDA of Pharmagreen Biotech was 471.00. The lowest was -412.09. And the median was 0.00.

PHBI's EV-to-EBITDA is ranked worse than
100% of 710 companies
in the Drug Manufacturers industry
Industry Median: 14.875 vs PHBI: -1.96

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Pharmagreen Biotech's stock price is $0.0006. Pharmagreen Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.000. Therefore, Pharmagreen Biotech's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Pharmagreen Biotech EV-to-EBITDA Historical Data

The historical data trend for Pharmagreen Biotech's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech EV-to-EBITDA Chart

Pharmagreen Biotech Annual Data

Trend

Apr08

Apr09

Sep18

Sep19

Sep20

Sep21

Sep22

EV-to-EBITDA

Get a 7-Day Free Trial

-58.85

-198.05

-4.60

-2.84

-5.68

Pharmagreen Biotech Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
EV-to-EBITDA	Get a 7-Day Free Trial															-2.48	-5.68	-1.97	360.41	-2.86

Competitive Comparison of Pharmagreen Biotech's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmagreen Biotech's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Pharmagreen Biotech's EV-to-EBITDA falls into.

Pharmagreen Biotech EV-to-EBITDA Calculation

Pharmagreen Biotech's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	0.792	/	-0.405
	=	-1.96

Pharmagreen Biotech's current Enterprise Value is $0.79 Mil.
Pharmagreen Biotech's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.41 Mil.

Pharmagreen Biotech (OTCPK:PHBI) EV-to-EBITDA Explanation

Pharmagreen Biotech's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.0006	/	0.000
	=	N/A

Pharmagreen Biotech's share price for today is $0.0006.
Pharmagreen Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Pharmagreen Biotech EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Pharmagreen Biotech's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

112 North Curry Street, Carson, NV, USA, 89703

Website

https://www.pharmagreen.ca

Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.